<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03189316</url>
  </required_header>
  <id_info>
    <org_study_id>9828</org_study_id>
    <nct_id>NCT03189316</nct_id>
  </id_info>
  <brief_title>Anti-inflammatory Cells in Peritoneal Cavity</brief_title>
  <official_title>Can the Peritoneal Cavity be a Source of Regulatory B Cells to Treat Auto-immune Disease?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre National de la Recherche Scientifique, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Some subsets of lymphocytes are able to inhibit immune response and thus, could be used to&#xD;
      control auto-immune diseases and transplant reject. In mice, the main source of those&#xD;
      anti-inflammatory lymphocytes is the peritoneal cavity. No data are available in human. This&#xD;
      study aims at exploring the presence of those anti-inflammatory lymphocytes in human&#xD;
      peritoneal cavity and at determine how to expand those cells.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      B cells will be collected during procedures planned for patients' standard care. Peritoneal&#xD;
      fluid and peripheral blood of patients will be collected during coelioscopy for exploration&#xD;
      of ovarian cysts or dialysis for treatment of chronic renal insufficiency.&#xD;
&#xD;
      Regulatory B cells (Breg cells) will be measured in peritoneal fluid and in peripheral blood&#xD;
      after in vitro stimulation and assessment of intracellular interleukin-10 by flow cytometry.&#xD;
      Proportion of Breg cells among B cells will be compared between peritoneal fluid and&#xD;
      peripheral blood in both groups.&#xD;
&#xD;
      Different protocols to induce differentiation of B cells into Breg cells will be tested and&#xD;
      compared.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Absence of BReg Lymphocytes in peritoneum&#xD;
  </why_stopped>
  <start_date type="Actual">June 6, 2017</start_date>
  <completion_date type="Actual">December 13, 2017</completion_date>
  <primary_completion_date type="Actual">December 13, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>relative percentage of regulatory B cells among B cells in peritoneal cavity compared to peripheral blood</measure>
    <time_frame>up to 48 hour</time_frame>
    <description>Comparison of Breg cell in peritoneal cavity to Breg cell in peripheral blood B</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Ovarian Cysts</condition>
  <condition>Chronic Renal Insufficiency</condition>
  <arm_group>
    <arm_group_label>subjects with ovarian cyst</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Peritoneal fluid sample obtained from coelioscopy for exploration of ovarian cysts and blood sample</description>
  </arm_group>
  <arm_group>
    <arm_group_label>subjects with peritoneal dialysis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Peritoneal fluid sample obtained from peritoneal dialysis fluid of patients with chronic renal insufficiency and blood sample</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>peritoneal fluid and blood sample</intervention_name>
    <description>Peritoneal fluid sample obtained from peritoneal dialysis fluid of patients with chronic renal insufficiency and blood sample or Peritoneal fluid obtained from coelioscopy for exploration of ovarian cysts and blood cell</description>
    <arm_group_label>subjects with ovarian cyst</arm_group_label>
    <arm_group_label>subjects with peritoneal dialysis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  woman over 18 year old undergoing exploration of ovarian cysts by coelioscopy&#xD;
&#xD;
          -  patient with chronic renal insufficiency undergoing peritoneal dialysis&#xD;
&#xD;
          -  informed consent obtained&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  pregnancy or breast-feeding&#xD;
&#xD;
          -  non affiliation to health care insurance&#xD;
&#xD;
          -  treatment with corticosteroids over 15 mg/day&#xD;
&#xD;
          -  treatment with rituximab&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU montpellier - department of rheumatology</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>May 30, 2017</study_first_submitted>
  <study_first_submitted_qc>June 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 16, 2017</study_first_posted>
  <last_update_submitted>June 12, 2018</last_update_submitted>
  <last_update_submitted_qc>June 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Peritoneal fluid</keyword>
  <keyword>B cells</keyword>
  <keyword>Regulatory B cells</keyword>
  <keyword>Human</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Cysts</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

